GNPX - Genprex, Inc.
1.95
-0.050 -2.564%
Share volume: 316,359
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.00
-0.05
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-09-2024 | 11-13-2024 | 05-12-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | -620.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | -620.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| inf% | 100.00% | nan% | nan% | nan% | |||
| Operating expenses | 5.994 M | 6.516 M | 4.322 M | 3.969 M | 4.682 M | 3.346 M | |
| Selling general and admin | 2.720 M | 4.849 M | 1.566 M | 1.429 M | 2.182 M | 1.153 M | |
| Research and development | 3.274 M | 1.667 M | 2.756 M | 2.540 M | 2.499 M | 2.193 M | |
| Total expenses | 5.997 M | 6.518 M | 4.323 M | 3.969 M | 4.682 M | 3.346 M | |
| 8.70% | -33.67% | -8.19% | 17.95% | -28.53% | |||
| Operating income | -5.997 M | -6.518 M | -4.323 M | -3.969 M | -4.682 M | -3.346 M | |
| Ebit | -5.997 M | -6.518 M | -4.324 M | -3.969 M | -4.682 M | -3.802 M | |
| Pretax income | -5.969 M | -6.495 M | -4.316 M | -3.965 M | -4.675 M | -3.799 M | |
| 8.82% | -33.55% | -8.14% | 17.92% | -18.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.969 M | -6.496 M | -4.316 M | -3.965 M | -4.675 M | -3.799 M | |
| -8.83% | 33.56% | 8.14% | -17.92% | 18.73% |